Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Karyopharm Therapeutics Inc. (KPTI)

6.1   0.31 (5.35%) 05-23 16:00
Open: 5.25 Pre. Close: 5.23
High: 5.81 Low: 5.02
Volume: 3,840,286 Market Cap: 371M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.431 - 6.453 6.453 - 6.474
Low: 5.641 - 5.668 5.668 - 5.692
Close: 6.056 - 6.095 6.095 - 6.13

Technical analysis

as of: 2019-05-23 4:26:28 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 7.51     One year: 8.77
Support: Support1: 5.09    Support2: 4.26
Resistance: Resistance1: 6.43    Resistance2: 7.51
Pivot: 4.92
Moving Average: MA(5): 5.38     MA(20): 4.88
MA(100): 6.51     MA(250): 11.84
MACD: MACD(12,26): 0.11     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 83.62     %D(3): 76.80
RSI: RSI(14): 71.17
52-week: High: 21.71  Low: 3.92  Change(%): -64.8
Average Vol(K): 3-Month: 125361  10-Days: 140306

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
KPTI has closed above the upper band by 14.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 19.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 17 May 2019 14:08:54 Z
Karyopharm Therapeutics Inc. (KPTI) Q1 2019 Earnings Call Transcript

Thu, 09 May 2019 15:07:16 Z
Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Misses Revenue Estimates

Thu, 02 May 2019 17:14:21 Z
Earnings Preview: Karyopharm Therapeutics (KPTI) Q1 Earnings Expected to Decline

Mon, 18 Mar 2019 22:08:41 Z
Here's Why Karyopharm Therapeutics Climbed Today

Mon, 18 Mar 2019 17:11:15 Z
Karyopharm Stock Up Even as FDA Delays Selinexor NDA Verdict

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 60.86
Shares Float (M) 59.48
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -3.130
EPS Est. Current Year -2.620
EPS Est. Next Year -2.310
EPS Est. Next Quarter -0.610
Forward EPS -2.559
Book Value (p.s.) 2.350
PEG Ratio 0.04
Profit Margin
Operating Margin -1004.65
Return on Assets (ttm) -98.0
Return on Equity (ttm) -197.9
Qtrly Rev. Growth -98.5
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -191.09
Levered Free Cash Flow (M) -122.04

Stock Valuations

P/E -1.95
P/E Growth Ratio 0.05
P/BV 2.60
P/S 1091900032.00
P/CF -1.94

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.